ATRENEW INC (RERE) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:RERE • US00138L1089

5.475 USD
-0.06 (-0.99%)
Last: Feb 5, 2026, 09:35 AM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to RERE. RERE was compared to 121 industry peers in the Specialty Retail industry. RERE has a great financial health rating, but its profitability evaluates not so good. RERE is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • RERE had positive earnings in the past year.
  • In the past 5 years RERE always reported negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: RERE reported negative operating cash flow in multiple years.
RERE Yearly Net Income VS EBIT VS OCF VS FCFRERE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B

1.2 Ratios

  • RERE's Return On Assets of 5.34% is fine compared to the rest of the industry. RERE outperforms 71.07% of its industry peers.
  • RERE's Return On Equity of 7.28% is fine compared to the rest of the industry. RERE outperforms 61.98% of its industry peers.
  • RERE has a better Return On Invested Capital (6.73%) than 63.64% of its industry peers.
Industry RankSector Rank
ROA 5.34%
ROE 7.28%
ROIC 6.73%
ROA(3y)-17.29%
ROA(5y)-20.7%
ROE(3y)-22.67%
ROE(5y)-27.41%
ROIC(3y)N/A
ROIC(5y)N/A
RERE Yearly ROA, ROE, ROICRERE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

  • The Profit Margin of RERE (1.44%) is comparable to the rest of the industry.
  • RERE has a Operating Margin (1.72%) which is in line with its industry peers.
  • With a Gross Margin value of 12.19%, RERE is not doing good in the industry: 87.60% of the companies in the same industry are doing better.
  • RERE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.72%
PM (TTM) 1.44%
GM 12.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.4%
GM growth 5Y35.7%
RERE Yearly Profit, Operating, Gross MarginsRERE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so RERE is destroying value.
  • Compared to 1 year ago, RERE has less shares outstanding
  • The number of shares outstanding for RERE remains at a similar level compared to 5 years ago.
  • The debt/assets ratio for RERE has been reduced compared to a year ago.
RERE Yearly Shares OutstandingRERE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
RERE Yearly Total Debt VS Total AssetsRERE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • There is no outstanding debt for RERE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.8
WACC8.44%
RERE Yearly LT Debt VS Equity VS FCFRERE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 3.30 indicates that RERE has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.30, RERE belongs to the top of the industry, outperforming 89.26% of the companies in the same industry.
  • RERE has a Quick Ratio of 2.77. This indicates that RERE is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 2.77, RERE belongs to the best of the industry, outperforming 92.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.3
Quick Ratio 2.77
RERE Yearly Current Assets VS Current LiabilitesRERE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 441.18% over the past year.
  • The Revenue has grown by 27.94% in the past year. This is a very strong growth!
  • Measured over the past years, RERE shows a very strong growth in Revenue. The Revenue has been growing by 32.94% on average per year.
EPS 1Y (TTM)441.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.62%
Revenue 1Y (TTM)27.94%
Revenue growth 3Y28.03%
Revenue growth 5Y32.94%
Sales Q2Q%27.1%

3.2 Future

  • Based on estimates for the next years, RERE will show a very strong growth in Earnings Per Share. The EPS will grow by 180.68% on average per year.
  • RERE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 25.48% yearly.
EPS Next Y531.48%
EPS Next 2Y231.38%
EPS Next 3Y180.68%
EPS Next 5YN/A
Revenue Next Year28.57%
Revenue Next 2Y26.78%
Revenue Next 3Y25.48%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
RERE Yearly Revenue VS EstimatesRERE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10B 20B 30B
RERE Yearly EPS VS EstimatesRERE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 30.42 indicates a quite expensive valuation of RERE.
  • Compared to the rest of the industry, the Price/Earnings ratio of RERE indicates a somewhat cheap valuation: RERE is cheaper than 62.81% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 28.25, RERE is valued at the same level.
  • With a Price/Forward Earnings ratio of 18.85, RERE is valued on the expensive side.
  • RERE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. RERE is cheaper than 66.12% of the companies in the same industry.
  • RERE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.50.
Industry RankSector Rank
PE 30.42
Fwd PE 18.85
RERE Price Earnings VS Forward Price EarningsRERE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RERE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.32
RERE Per share dataRERE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as RERE's earnings are expected to grow with 180.68% in the coming years.
PEG (NY)0.06
PEG (5Y)N/A
EPS Next 2Y231.38%
EPS Next 3Y180.68%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for RERE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ATRENEW INC

NYSE:RERE (2/5/2026, 9:35:59 AM)

5.475

-0.06 (-0.99%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-20
Earnings (Next)03-09
Inst Owners41.44%
Inst Owner Change-1.02%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.21B
Revenue(TTM)19.64B
Net Income(TTM)283.00M
Analysts85.71
Price Target7.45 (36.07%)
Short Float %1.29%
Short Ratio1.57
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-27.98%
Min EPS beat(2)-29.48%
Max EPS beat(2)-26.47%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.47%
Min Revenue beat(2)-1.11%
Max Revenue beat(2)2.05%
Revenue beat(4)1
Avg Revenue beat(4)-0.31%
Min Revenue beat(4)-1.18%
Max Revenue beat(4)2.05%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.69%
PT rev (3m)46.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)373.61%
EPS NY rev (3m)394.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.73%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)0.08%
Valuation
Industry RankSector Rank
PE 30.42
Fwd PE 18.85
P/S 0.43
P/FCF N/A
P/OCF N/A
P/B 2.17
P/tB 2.17
EV/EBITDA 14.32
EPS(TTM)0.18
EY3.29%
EPS(NY)0.29
Fwd EY5.3%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS12.76
BVpS2.53
TBVpS2.52
PEG (NY)0.06
PEG (5Y)N/A
Graham Number3.2
Profitability
Industry RankSector Rank
ROA 5.34%
ROE 7.28%
ROCE 8.52%
ROIC 6.73%
ROICexc 6.73%
ROICexgc 6.75%
OM 1.72%
PM (TTM) 1.44%
GM 12.19%
FCFM N/A
ROA(3y)-17.29%
ROA(5y)-20.7%
ROE(3y)-22.67%
ROE(5y)-27.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.4%
GM growth 5Y35.7%
F-ScoreN/A
Asset Turnover3.71
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.3
Quick Ratio 2.77
Altman-Z N/A
F-ScoreN/A
WACC8.44%
ROIC/WACC0.8
Cap/Depr(3y)21.03%
Cap/Depr(5y)18.67%
Cap/Sales(3y)0.55%
Cap/Sales(5y)0.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)441.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.62%
EPS Next Y531.48%
EPS Next 2Y231.38%
EPS Next 3Y180.68%
EPS Next 5YN/A
Revenue 1Y (TTM)27.94%
Revenue growth 3Y28.03%
Revenue growth 5Y32.94%
Sales Q2Q%27.1%
Revenue Next Year28.57%
Revenue Next 2Y26.78%
Revenue Next 3Y25.48%
Revenue Next 5YN/A
EBIT growth 1Y931.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year29.16%
EBIT Next 3Y38.86%
EBIT Next 5YN/A
FCF growth 1Y266.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y163.53%
OCF growth 3YN/A
OCF growth 5YN/A

ATRENEW INC / RERE FAQ

What is the fundamental rating for RERE stock?

ChartMill assigns a fundamental rating of 5 / 10 to RERE.


What is the valuation status for RERE stock?

ChartMill assigns a valuation rating of 4 / 10 to ATRENEW INC (RERE). This can be considered as Fairly Valued.


What is the profitability of RERE stock?

ATRENEW INC (RERE) has a profitability rating of 3 / 10.


What are the PE and PB ratios of ATRENEW INC (RERE) stock?

The Price/Earnings (PE) ratio for ATRENEW INC (RERE) is 30.42 and the Price/Book (PB) ratio is 2.17.


What is the expected EPS growth for ATRENEW INC (RERE) stock?

The Earnings per Share (EPS) of ATRENEW INC (RERE) is expected to grow by 531.48% in the next year.